These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31406047)

  • 1. [Next generation zebrafish-based drug discovery and precision medicine].
    Tanaka T; Koiwa J
    Nihon Yakurigaku Zasshi; 2019; 154(2):78-83. PubMed ID: 31406047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zebrafish Xenografts for Drug Discovery and Personalized Medicine.
    Xiao J; Glasgow E; Agarwal S
    Trends Cancer; 2020 Jul; 6(7):569-579. PubMed ID: 32312681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cancer cell transplantation in zebrafish: From translational research to personalized medicine].
    Raby L; Völkel P; Le Bourhis X; Angrand PO
    Bull Cancer; 2020 Jan; 107(1):30-40. PubMed ID: 31466696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zebrafish Avatar to Develop Precision Breast Cancer Therapies.
    Corsinovi D; Usai A; Sarlo M; Giannaccini M; Ori M
    Anticancer Agents Med Chem; 2022; 22(4):748-759. PubMed ID: 33797388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Big data: the next frontier for innovation in therapeutics and healthcare.
    Issa NT; Byers SW; Dakshanamurthy S
    Expert Rev Clin Pharmacol; 2014 May; 7(3):293-8. PubMed ID: 24702684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personalized
    Pauli C; Hopkins BD; Prandi D; Shaw R; Fedrizzi T; Sboner A; Sailer V; Augello M; Puca L; Rosati R; McNary TJ; Churakova Y; Cheung C; Triscott J; Pisapia D; Rao R; Mosquera JM; Robinson B; Faltas BM; Emerling BE; Gadi VK; Bernard B; Elemento O; Beltran H; Demichelis F; Kemp CJ; Grandori C; Cantley LC; Rubin MA
    Cancer Discov; 2017 May; 7(5):462-477. PubMed ID: 28331002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations.
    Tebani A; Afonso C; Marret S; Bekri S
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Power of Zebrafish in Personalised Medicine.
    Baxendale S; van Eeden F; Wilkinson R
    Adv Exp Med Biol; 2017; 1007():179-197. PubMed ID: 28840558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promise of personalized omics to precision medicine.
    Chen R; Snyder M
    Wiley Interdiscip Rev Syst Biol Med; 2013; 5(1):73-82. PubMed ID: 23184638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision medicine and oncology: an overview of the opportunities presented by next-generation sequencing and big data and the challenges posed to conventional drug development and regulatory approval pathways.
    Doherty M; Metcalfe T; Guardino E; Peters E; Ramage L
    Ann Oncol; 2016 Aug; 27(8):1644-6. PubMed ID: 27117532
    [No Abstract]   [Full Text] [Related]  

  • 11. Genomic Medicine Without Borders: Which Strategies Should Developing Countries Employ to Invest in Precision Medicine? A New "Fast-Second Winner" Strategy.
    Mitropoulos K; Cooper DN; Mitropoulou C; Agathos S; Reichardt JKV; Al-Maskari F; Chantratita W; Wonkam A; Dandara C; Katsila T; Lopez-Correa C; Ali BR; Patrinos GP
    OMICS; 2017 Nov; 21(11):647-657. PubMed ID: 29140767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using zebrafish models of leukemia to streamline drug screening and discovery.
    Deveau AP; Bentley VL; Berman JN
    Exp Hematol; 2017 Jan; 45():1-9. PubMed ID: 27720937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zebrafish patient avatars in cancer biology and precision cancer therapy.
    Fazio M; Ablain J; Chuan Y; Langenau DM; Zon LI
    Nat Rev Cancer; 2020 May; 20(5):263-273. PubMed ID: 32251397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fishing the targets of myeloid malignancies in the era of next generation sequencing.
    Shi X; He BL; Ma AC; Leung AY
    Blood Rev; 2016 Mar; 30(2):119-30. PubMed ID: 26443083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facilitating tailored therapeutic strategies for glioblastoma through an orthotopic patient-derived xenograft platform.
    Lee HW; Lee K; Kim DG; Yang H; Nam DH
    Histol Histopathol; 2016 Mar; 31(3):269-83. PubMed ID: 26578300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatiotemporal diversification of intrapatient genomic clones and early drug development concepts realize the roadmap of precision cancer medicine.
    Roukos DH
    Drug Discov Today; 2017 Aug; 22(8):1148-1164. PubMed ID: 28400153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hooking the big one: the potential of zebrafish xenotransplantation to reform cancer drug screening in the genomic era.
    Veinotte CJ; Dellaire G; Berman JN
    Dis Model Mech; 2014 Jul; 7(7):745-54. PubMed ID: 24973744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategy of Daiichi Sankyo discovery research in oncology.
    Akahane K; Hirokawa K
    Jpn J Clin Oncol; 2014 Feb; 44(2):109-15. PubMed ID: 24459194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Making individualized drugs a reality.
    Schellekens H; Aldosari M; Talsma H; Mastrobattista E
    Nat Biotechnol; 2017 Jun; 35(6):507-513. PubMed ID: 28581491
    [No Abstract]   [Full Text] [Related]  

  • 20. Feasibility of Ultra-High-Throughput Functional Screening of Melanoma Biopsies for Discovery of Novel Cancer Drug Combinations.
    Friedman AA; Xia Y; Trippa L; Le LP; Igras V; Frederick DT; Wargo JA; Tanabe KK; Lawrence DP; Neuberg DS; Flaherty KT; Fisher DE
    Clin Cancer Res; 2017 Aug; 23(16):4680-4692. PubMed ID: 28446504
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.